Effects of non-ionic monomeric and dimeric iodinated contrast media on renal and systemic haemodynamics in rats

Fundamental and Clinical Pharmacology

Volumn 14, Issue 1, 2000, Pages 11-18

  Idée, Jean Marc ^a   Lancelot, Eric ^a   Berthommier, Christine ^a   Couturier Goulas, Valérie ^a   Vazin, Véronique ^a   Corot, Claire ^a  

^a Laboratoire Guerbet   (France)

Author keywords

Contrast medium; Iobitridol; Iodixanol; Nephrotoxicity; Renal blood flow

Indexed keywords

IOBITRIDOL; IODINATED CONTRAST MEDIUM; IODIXANOL; MONOMERIC NONIONIC CONTRAST MEDIUM;

ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR AUTOREGULATION; CONTROLLED STUDY; DRUG EFFECT; KIDNEY BLOOD FLOW; KIDNEY PERFUSION; MALE; NONHUMAN; OSMOLALITY; PRIORITY JOURNAL; RAT; SYSTEMIC CIRCULATION;

EID: 0033967833     PISSN: 07673981     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1472-8206.2000.tb00388.x     Document Type: Article

References (37)

1. [1] Idée J.-M., Beaufils H., Bonnemain B., Iodinated contrast media-induced nephropathy: pathophysiology, clinical aspects and prevention, Fundam. Clin. Pharmacol. 8 (1994) 193 206.
2. [2] Rudnick M.R., Berns J.S., Cohen R.M., Goldfarb S., Contrast media-associated nephrotoxicity, Curr. Op. Nephrol. Hypert. 5 (1996) 127 133.
3. [3] Morcos S.K., El Nahas A.M., Advances in the understanding of the nephrotoxicity of radiocontrast media, Nephron 78 (1998) 249 252.
4. [4] Heyman S.N., Rosen S., Brezis M., Radiocontrast nephropathy: a paradigm for the synergism between toxic and hypoxic insults in the kidney, Exp. Nephrol. 2 (1994) 153-157.
5. [5] Barrett B.J, Carlisle E.J., Meta-analysis of the relative nephrotoxicity of high and low-osmolality iodinated contrast media, Radiology 188 (1993) 171-178.
6. [6] Deray G., Jacobs C., Renal tolerance of non-ionic dimers, Invest. Radiol. 31 (1996) 372-377.
7. [7] Stacul F., Thomsen H.S., Non-ionic monomers and dimers, Eur. Radiol. 6 (1996) 756 761.
8. [8] Katzberg R.W., Morris T.W., Lasser E.C., DiMarco P.L., Merguerian P.A., Ventura J.A., Pabico R.C., McKenna B.A., Acute systemic and renal haemodynamic effects of meglumine/ sodium diatrizoale 76% and iopamidol in euvolemic and dehydrated dogs, Invest. Radiol. 21 (1986) 793-797.
9. [9] Tornquist C., Almén T., Golman K., Hollas S., Renal function following nephroangiography with metrizamide and iohexol. Effects on renal blood flow, glomerular permeability and filtration rate and diuresis in dogs, Acta Radiol. Diagn. 26 (1985) 483-489.
10. [10] Milliken G.A., Analysis of repeated measures design, in: Berry D.A. (Ed.), Statistical Methodology in the Pharmaceutical Sciences, Dekker, New York, 1990, pp. 83 116.
11. [11] Waynforth H.B., Experimental and Surgical Technique in the Rat, Academic Press, London, 1980.
12. [12] Griffin K.A., Bidani A.K., Picken M., Ellis V.R., Churchill P.C., Prostaglandins do not mediate autoregulation or increased renin secretion in remnant rat kidneys, Am. J. Physiol. 263 (1992) F1057 F1062.
13. [13] Parker J.L., Adams R., The influence of chemical restraining agents on cardiovascular function: a review, Lab. Anim. Sci. 28 (1978) 575-583.
14. [14] Leeming B.W.A., Spokes K.C., Suva P., Effect of meglumine iothalamate on renal haemodynamics and function in the diabetic rat, Invest. Radiol. 20 (1985) 971-977.
15. [15] Conger J.D., Burke T.J., Effects of anaesthetic agents on autoregulation of renal haemodynamics in the rat and dog. Am. J. Physiol. 230 (1976) 652-657.
16. [16] Kramp R.A., Genard J., Fourmanoir P., Caron N., Laekeman G., Herman A., Renal haemodynamics and blood flow autoregulation during acute cyclooxygenase inhibition in male rats, Am. J. Physiol. 268 (1995) F468 F479.
17. [17] Idée J.M., Bonnemain B., Reliability of experimental models of iodinated contrast media-induced acute renal failure. From methodological considerations to pathophysiology, Invest. Radiol. 31 (1996) 230 241.
18. [18] Welch W.J., Deng X., Snellen H., Wilcox C.S., Validation of miniature ultrasonic transit-time flow probes for measurement of renal blood flow in rats, Am. J. Physiol. 268 (1995) F175-F178.
19. [19] Wen C., Li M., Whithworth J.A., Validation of transonic small animal flowmeter for measurement of cardiac output and regional blood flow in the rat, J. Cardiovasc. Pharmacol. 27 (1996) 482 486.
20. [20] Hoogewoud H.M., Woessmer B., Tobitridol 300 compared to iopromide 300. A double-blind randomized phase-III study of clinical tolerance in total body CT, Acta Radiol. 37 (suppl. 400) (1996) 62 64.
21. [21] Baumgart D., Haude M., George G., Ge J., Rosenbaum S., Caspari G., Liu F., Erbel R., High-volume non-ionic dimeric contrast medium: first experiences during complex coronary interventions, Cath. Cardiovasc. Diagn. 40 (1997) 241 246.
22. [22] Grainger R.G., Osmolality of intravascular radiological contrast media, Br. J. Radiol. 53 (1980) 739 746.
23. [23] Klow N.E., Jacobsen E.A., Refsum H., Cardioangiography and the haemodynamic effects of iodixanol, Acta Radiol. 36 (suppl. 399) (1995) 93-99.
24. [24] Deray G., Bagnis C., Jacquiaud C., Dubois M., Adabra Y., Jaudon C., Renal effects of low and isoosmolar contrast media on renal haemodynamics in a normal and ischaemic dog kidney, Invest. Radiol. 34 (1999) 1-4.
25. [25] Pugh N.D., Griffith T.M., Karlsson J.O.G., Effects of iodinated contrast media on peripheral blood flow, Acta Radiol. 36 (suppl. 399) (1995) 155-163.
26. [26] Pitman M.R., Karlsson J.O.G., Griffith T.M., Ionic mechanisms contributing to the vasorelaxant properties of iodinated contrast media: a comparison of iohexol and iodixanol in the rabbit isolated aorta, Br. J. Pharmacol. 119 (1996) 685 690.
27. [27] Heglund I.F., Michelet A.A., Blazak W.F., Furuhama K., Holtz E., Preclinical pharmacokinetics and general toxicology of iodixanol, Acta Radiol. 36 (suppl. 399) (1995) 69-82.
28. [28] Harris J.M., West G.B., Rats resistant to the dextran anaphylactoid reaction, Brit. J. Pharmacol. 20 (1963) 550-562.
29. [29] Heyman S.N., Clark B.A., Kaiser N., Spokes K., Rosen S., Brezis M., Epstein F., Radiocontrast agents induce endothelin release in vivo and in vitro, J. Am. Soc. Nephrol. 3 (1992) 58 65.
30. [30] Arakawa K., Suzuki H., Naitoh M., Matsumoto A., Hayashi K., Matsuda H., Ichihara A., Kubota E., Saruta T., Role of adenosine in the renal responses to contrast medium, Kidney Int. 49 (1996) 1199-1206.
31. [31] Liss P., Nygren A., Hansell P., Influence of iotrolan on renal cortical and outer medullary blood flow in the rat, Acad. Radiol. 5 (suppl. 1) (1998) S123-S126.
32. [32] Ueda J., Nygren A., Hansell P., Erikson U., Influence of contrast media on single nephron glomerular filtration rate in rat kidney, Acta Radiol. 33 (1992) 596-599.
33. [33] Ueda J., Nygren A., Hansell P., Ulfendahl H.R., Effect of intravenous contrast media on proximal and distal tubular hydrostatic pressure in the rat kidney, Acta Radiol. 34 (1993) 83 87.
34. [34] Ueda J., Furukawa T., Higashino K., Takahashi S., Araki Y., Kubo K., Nakashima T., Urine viscosity after injections of iotrolan or iomcprol, Acta Radiol. 38 (1997) 1079 1082.
35. [35] Jakobsen J.A., Lundby B., Kristoffersen D.T., Borch K.W., Hald J.K., Berg K.J., Evaluation of renal function with delayed CT after injection of non-ionic monomeric and dimeric contrast media in healthy volunteers, Radiology 182 (1992) 419 424.
36. [36] Jakobsen J.A., Berg K.J., Kjoersgaard P., Kolmannskog F., Nordal K.P., Nossen J.O., Rootwelt K., Angiography with non-ionic X-ray contrast media in severe chronic renal failure: renal function and contrast retention, Nephron 73 (1996) 549 556.
37. [37] Carraro M., Malalan F., Antonione R., Stacul F., Cova M., Petz S. et al., Effects of a dimeric vs. a monomeric non-ionic contrast medium on renal function in patients with mild to moderate renal insufficiency: a double-blind, randomized clinical trial. Eur. Radiol. 8 (1998) 144 147.